Related Experiment Video
Updated: Aug 20, 2025

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
Published on: June 26, 2018
Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis
Caitlin Coombes1, Keisuke Horikawa2, Sanjiv Jain3
1School of Medicine and Psychology, College of Health and Medicine, Australian National University, Canberra, ACT, Australia; Haematology Translational Research Unit, Haematology Department, Canberra Health Services, Canberra, ACT, Australia.
Diffuse large B-cell lymphoma (DLBCL) is linked to red cell autoimmunity, evidenced by direct antiglobulin test (DAT) positivity. Specific gene mutations, like BIRC3 and FOXO1, were found only in DAT-positive DLBCL, suggesting potential therapeutic targets.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Diffuse large B-cell lymphoma (DLBCL) is the most prevalent B-cell non-Hodgkin lymphoma (B-NHL), associated with significant morbidity and mortality.
- Autoimmune diseases and lymphomas share underlying breakdowns in cell regulatory pathways, with epidemiological links suggesting bidirectional risk.
- Red cell autoimmunity, indicated by direct antiglobulin test (DAT) positivity, has been associated with DLBCL, with emerging molecular insights into its pathogenesis.
Purpose of the Study:
- To investigate the relationship between red cell autoimmunity and DLBCL.
- To identify specific genetic mutations associated with DAT positivity in DLBCL patients.
- To explore the role of immunoglobulin genotype IGHV4-34 in antigen-driven lymphomagenesis in DLBCL.
Main Methods:
- Comparison of DAT positivity rates between DLBCL patients and healthy controls.
- High-throughput sequencing to analyze gene mutations in DLBCL samples from DAT-positive (DAT+) and DAT-negative (DAT-) patients.
- Analysis of immunoglobulin genotype IGHV4-34 and its hydrophobic patch mutations in DLBCL clones.
Main Results:
- DAT positivity was significantly more common in DLBCL patients (20.4%) than in healthy controls (3.7%).
- Mutations in BIRC3, FOXO1, and CARD11 were exclusively found in DAT+ DLBCL samples.
- IGHV4-34 was over-represented in the DLBCL cohort, with unmutated hydrophobic patch mutations observed in 5 out of 6 IGHV4-34-expressing samples, suggesting antigen-driven lymphomagenesis.
Conclusions:
- Red cell autoimmunity is a significant finding in DLBCL, potentially linked to specific genetic mutations.
- Mutations in genes such as BIRC3, FOXO1, and CARD11 may play a role in DLBCL development in the context of red cell autoimmunity.
- The findings support the antigen-driven lymphomagenesis theory, particularly for IGHV4-34-expressing DLBCL, and highlight potential targets for future therapies.
Related Concept Videos
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Cells of the Adaptive Immune Response
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...

